Publications by authors named "Timothy C Rodell"

Claim this Profile
A
A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer.
Peter Muscarella, Tanios Bekaii-Saab, Kristi McIntyre, Alexander Rosemurgy, Sharona B Ross, Timothy C Rodell

J Pancreat Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Carolina Boni, Harry L A Janssen, Marzia Rossi, Seung Kew Yoon, Andrea Vecchi, Timothy C Rodell

Gastroenterology· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial.
Allen Cohn, Michael A Morse, Bert O'Neil, Samuel Whiting, Claire Coeshott, Timothy C Rodell

J Immunother· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and Immunogenicity Testing of Whole Recombinant Yeast-Based T-Cell Vaccines.
Thomas H King, Zhimin Guo, Melanie Hermreck, Donald Bellgrau, Timothy C Rodell

Methods Mol Biol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.
Christopher R Heery, B Harpreet Singh, Myrna Rauckhorst, Jennifer L Marté, Renee N Donahue, Timothy C Rodell

Cancer Immunol Res· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.
Jo A Tucker, Caroline Jochems, Benjamin Boyerinas, Jonathan Fallon, John W Greiner, Timothy C Rodell

Cancer Immunol Immunother· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.
David M Hockenbery, Scott Cruickshank, Timothy C Rodell, Ted Gooley, Friedrich Schuening

Blood· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.
Aurelia A Haller, Georg M Lauer, Thomas H King, Charles Kemmler, Valerie Fiolkoski, Timothy C Rodell

Vaccine· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yeasts encoding tumour antigens in cancer immunotherapy.
Alex Franzusoff, Richard C Duke, Thomas H King, Yingnian Lu, Timothy C Rodell

Expert Opin Biol Ther· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy.
Yingnian Lu, Donald Bellgrau, Lori D Dwyer-Nield, Alvin M Malkinson, Richard C Duke, Timothy C Rodell

Cancer Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis